Clinical trial
Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
NCT03878628 is registered in ClinicalTrials.gov with Rigshospitalet, Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment With Allogeneic Adipose-derived Mesenchymal Stem Cells in Patients With Aqueous Deficient Dry Eye Disease
- Lead sponsor
- Rigshospitalet, Denmark
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 16, 2019
- Completion date
- February 20, 2023
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aqueous tear deficiency, dry eye, kerato conjunctivitis sicca